ArticleCancer biology & therapy2018

Temozolomide renders murine cancer cells susceptible to oncolytic adenovirus replication and oncolysis.

Rodolfo Garza-Morales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.